SUNPHARMA demonstrated a strong weekly performance, returning 0.51% with a relatively low volatility of 2.61%. This outperformance was notable compared to its peers, with DRREDDY, DIVISLAB, and HINDUNILVR all posting negative returns. The stock's Sharpe Ratio of 1.04 indicates a favorable risk-return profile, and the Max Drawdown of 0.0% suggests minimal downside risk. Overall, SUNPHARMA was a relatively safe and profitable bet this week.

[Volatility: 2.61%]